AngioDynamics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AngioDynamics and other ETFs, options, and stocks.

About ANGO

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. 

CEO
James Christopher Clemmer
CEOJames Christopher Clemmer
Employees
632
Employees632
Headquarters
Latham, New York
HeadquartersLatham, New York
Founded
1988
Founded1988
Employees
632
Employees632

ANGO Key Statistics

Market cap
520.21M
Market cap520.21M
Price-Earnings ratio
-15.66
Price-Earnings ratio-15.66
Dividend yield
—
Dividend yield—
Average volume
1.03M
Average volume1.03M
High today
$12.47
High today$12.47
Low today
$11.81
Low today$11.81
Open price
$11.93
Open price$11.93
Volume
631.33K
Volume631.33K
52 Week high
$16.29
52 Week high$16.29
52 Week low
$9.39
52 Week low$9.39

Stock Snapshot

As of today, AngioDynamics(ANGO) shares are valued at $12.12. The company's market cap stands at 520.21M, with a P/E ratio of -15.66.

On 2026-10-23, AngioDynamics(ANGO) stock moved within a range of $11.81 to $12.47. With shares now at $12.12, the stock is trading +2.6% above its intraday low and -2.8% below the session's peak.

Trading volume for AngioDynamics(ANGO) stock has reached 631.33K, versus its average volume of 1.03M.

Over the past 52 weeks, AngioDynamics(ANGO) stock has traded between a high of $16.29 and a low of $9.39.

Over the past 52 weeks, AngioDynamics(ANGO) stock has traded between a high of $16.29 and a low of $9.39.

ANGO News

Investing.com 3d
AngioDynamics study shows survival benefit for pancreatic cancer - Investing.com

...

AngioDynamics study shows survival benefit for pancreatic cancer - Investing.com
TipRanks 3d
AngioDynamics announces two milestones for IRE

AngioDynamics (ANGO) announced two milestones for irreversible electroporation, IRE, the non-thermal ablation technology delivered by the NanoKnife System. The...

People also own

Based on the portfolios of people who own ANGO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.